Digoxin potentiation of the norepinephrine response in vascular smooth muscle

Stephen F. Flaim, John A. Zora, Robert Zelis

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

1. 1. Cardiac glycosides, in concentrations insufficient to produce vasoconstriction alone, are capable of potentiating the vasoconstrictor response in vascular smooth muscle to α-adrenergic stimulation. 2. 2. The data presented here suggest that digoxin potentiates the response to norepinephrine in vascular smooth muscle by a mechanism other than an alteration in cellular membrane potential or a facilitated influx in extracellular calcium ion alone. 3. 3. It is suggested that the mechanism of this response may be related to an augmented release of intracellular calcium stores.

Original languageEnglish (US)
Pages (from-to)201-206
Number of pages6
JournalGeneral Pharmacology
Volume10
Issue number3
DOIs
StatePublished - 1979

Fingerprint

Digoxin
Vascular Smooth Muscle
Norepinephrine
Calcium
Cardiac Glycosides
Vasoconstrictor Agents
Vasoconstriction
Adrenergic Agents
Membrane Potentials
Ions

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

Flaim, Stephen F. ; Zora, John A. ; Zelis, Robert. / Digoxin potentiation of the norepinephrine response in vascular smooth muscle. In: General Pharmacology. 1979 ; Vol. 10, No. 3. pp. 201-206.
@article{4f7ffd65057f4091ae375be9985d59a4,
title = "Digoxin potentiation of the norepinephrine response in vascular smooth muscle",
abstract = "1. 1. Cardiac glycosides, in concentrations insufficient to produce vasoconstriction alone, are capable of potentiating the vasoconstrictor response in vascular smooth muscle to α-adrenergic stimulation. 2. 2. The data presented here suggest that digoxin potentiates the response to norepinephrine in vascular smooth muscle by a mechanism other than an alteration in cellular membrane potential or a facilitated influx in extracellular calcium ion alone. 3. 3. It is suggested that the mechanism of this response may be related to an augmented release of intracellular calcium stores.",
author = "Flaim, {Stephen F.} and Zora, {John A.} and Robert Zelis",
year = "1979",
doi = "10.1016/0306-3623(79)90090-9",
language = "English (US)",
volume = "10",
pages = "201--206",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "3",

}

Digoxin potentiation of the norepinephrine response in vascular smooth muscle. / Flaim, Stephen F.; Zora, John A.; Zelis, Robert.

In: General Pharmacology, Vol. 10, No. 3, 1979, p. 201-206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Digoxin potentiation of the norepinephrine response in vascular smooth muscle

AU - Flaim, Stephen F.

AU - Zora, John A.

AU - Zelis, Robert

PY - 1979

Y1 - 1979

N2 - 1. 1. Cardiac glycosides, in concentrations insufficient to produce vasoconstriction alone, are capable of potentiating the vasoconstrictor response in vascular smooth muscle to α-adrenergic stimulation. 2. 2. The data presented here suggest that digoxin potentiates the response to norepinephrine in vascular smooth muscle by a mechanism other than an alteration in cellular membrane potential or a facilitated influx in extracellular calcium ion alone. 3. 3. It is suggested that the mechanism of this response may be related to an augmented release of intracellular calcium stores.

AB - 1. 1. Cardiac glycosides, in concentrations insufficient to produce vasoconstriction alone, are capable of potentiating the vasoconstrictor response in vascular smooth muscle to α-adrenergic stimulation. 2. 2. The data presented here suggest that digoxin potentiates the response to norepinephrine in vascular smooth muscle by a mechanism other than an alteration in cellular membrane potential or a facilitated influx in extracellular calcium ion alone. 3. 3. It is suggested that the mechanism of this response may be related to an augmented release of intracellular calcium stores.

UR - http://www.scopus.com/inward/record.url?scp=0018748651&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018748651&partnerID=8YFLogxK

U2 - 10.1016/0306-3623(79)90090-9

DO - 10.1016/0306-3623(79)90090-9

M3 - Article

C2 - 467959

AN - SCOPUS:0018748651

VL - 10

SP - 201

EP - 206

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 3

ER -